Evoq Remedies Reports FY26 Loss Amid Audit Concerns and SEBI Probe

Evoq Remedies Limited posted a net loss of ₹0.24 crore for the year ended March 31, 2026, a significant shift from a profit of ₹0.09 crore in the previous year. Revenue from operations surged by 117% to ₹25.51 crore.

Reader Takeaway: Revenue surge overshadowed by net loss, qualified audit, and SEBI probe.

What just happened

The company announced its audited financial results for FY26, revealing a net loss of ₹(0.24) crore, compared to a net profit of ₹0.09 crore in FY25. Revenue from operations saw a substantial increase of 117%, reaching ₹25.51 crore.

Why this matters

This results announcement is critical due to the 'Qualified Opinion' from the statutory auditor and a 'Material Uncertainty Related to Going Concern'. These highlight significant financial and compliance issues. Additionally, an ongoing SEBI investigation into the company's use of preferential issue funds adds regulatory risk.

The backstory

Evoq Remedies has been navigating financial challenges. The auditor's report points to non-compliance with related party loan regulations, unconfirmed balances for debtors and suppliers, and unpaid statutory dues like income tax and TDS.

What changes now

Investors face increased uncertainty. The qualified audit report and going concern warning signal potential operational and financial instability. The outcome of the SEBI investigation will be crucial in determining the future financial health and regulatory standing of the company.

Risks to watch

Key risks include the auditor's concerns about going concern, SEBI's investigation into ₹19.21 crore of preferential issue funds, and governance issues such as the failure to appoint an internal auditor and inadequate accounting software.

Peer comparison

(No peer comparison data available in the filing)

Context metrics (time-bound)

• Revenue FY26: ₹25.51 crore (vs. ₹11.76 crore in FY25)
• Net Profit/(Loss) FY26: ₹(0.24) crore (vs. ₹0.09 crore in FY25)
• Related Party Loans: ₹6.70 crore non-compliance
• Unconfirmed Debtors: ₹3.85 crore
• Unconfirmed Supplier Advances: ₹12.51 crore
• Unpaid Income Tax: ₹0.62 crore
• Unpaid TDS: ₹0.39 crore
• Disputed GST Demand: ₹6.55 crore
• Disputed Income Tax Demand: ₹1.88 crore
• SEBI Investigation Amount: ₹19.21 crore

What to track next

Investors should closely monitor the progress of the SEBI investigation, the company's efforts to regularize statutory dues and confirm balances, and any further updates on its going concern status.